Characteristic | TAX → FEC | FEC → TAX | P valuea |
---|---|---|---|
Age | 52 (37-70) | 48 (30-66) | 0.04b |
Pathology type | Â | Â | Â |
   Ductal | 25/31 (80.6) | 25/29 (86.2) | 1.00 |
   Ductal/lobular | 2/31 (6.5) | 1/29 (3.4) | n/a |
   Lobular | 4/31 (13.4) | 3/29 (10.3) | n/a |
Pathology grade | Â | Â | Â |
   Low | 4/31 (12.9) | 2/29 (6.9) | 0.41 |
   Medium | 11/31 (35.5) | 10/29 (34.5) | 0.82 |
   High | 16/31 (51.6) | 17/29 (58.6) | 0.86 |
Oestrogen receptor status | Â | Â | Â |
   Negative | 10/31 (32.2) | 13/29 (44.8) | 0.29 |
   Positive | 21/31 (67.7) | 16/29 (55.2) | 0.25 |
Progesterone receptor status | Â | Â | Â |
   Negative | 16/31 (51.6) | 18/29 (62.1) | 0.60 |
   Positive | 15/31 (48.4) | 11/29 (37.9) | 0.33 |
HER2 statusc | Â | Â | Â |
   Negative | 17/29 (58.6) | 16/29 (55.2) | 1.00 |
   Positive | 12/29 (41.4) | 13/29 (44.8) | 1.00 |
Surgical procedured | Â | Â | Â |
   Mastectomy | 16/30 (53.3) | 17/29 (58.6) | 0.86 |
   Wide local excision | 13/30 (43.3) | 12/29 (41.3) | 0.84 |
   Partial mastectomy | 1/30 (3.3) | 0/29 (0.0) | n/a |